Experience

TRAC

• United States
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Chief Data Scientist and Founding Partner

  • 2019 - Present

  Third Round Analytics Capital (TRAC) is a quant venture capital firm that uses proprietary technology to identify and invest in future unicorns and other hypergrowth startups (defined as startups that exit for greater than $250 million and return 5X invested capital). TRAC generally invests in the 3rd round of targeted startups. In 2015, DaaS Analytics (DaaS, the predecessor to TRAC) was founded to provide clients with a quantitative approach to identify top early-stage startup deal flow… Show more Third Round Analytics Capital (TRAC) is a quant venture capital firm that uses proprietary technology to identify and invest in future unicorns and other hypergrowth startups (defined as startups that exit for greater than $250 million and return 5X invested capital). TRAC generally invests in the 3rd round of targeted startups. In 2015, DaaS Analytics (DaaS, the predecessor to TRAC) was founded to provide clients with a quantitative approach to identify top early-stage startup deal flow sources from among thousands of accelerators and investors. DaaS's efforts evolved into algorithms that could identify Hypergrowth Companies. Developed over a 4-year period by analyzing tens of thousands of startups and investors, TRAC's algorithms would have identified 75% of last decade's Unicorns years before they were valued above $1billion. If you are an early stage investor who has invested in one or more unicorns, you may qualify to join the TRAC Community. Limited to 100 members, Community members gain access to TRAC technology, deal flow and can earn a share of TRAC's carry. Show less Third Round Analytics Capital (TRAC) is a quant venture capital firm that uses proprietary technology to identify and invest in future unicorns and other hypergrowth startups (defined as startups that exit for greater than $250 million and return 5X invested capital). TRAC generally invests in the 3rd round of targeted startups. In 2015, DaaS Analytics (DaaS, the predecessor to TRAC) was founded to provide clients with a quantitative approach to identify top early-stage startup deal flow… Show more Third Round Analytics Capital (TRAC) is a quant venture capital firm that uses proprietary technology to identify and invest in future unicorns and other hypergrowth startups (defined as startups that exit for greater than $250 million and return 5X invested capital). TRAC generally invests in the 3rd round of targeted startups. In 2015, DaaS Analytics (DaaS, the predecessor to TRAC) was founded to provide clients with a quantitative approach to identify top early-stage startup deal flow sources from among thousands of accelerators and investors. DaaS's efforts evolved into algorithms that could identify Hypergrowth Companies. Developed over a 4-year period by analyzing tens of thousands of startups and investors, TRAC's algorithms would have identified 75% of last decade's Unicorns years before they were valued above $1billion. If you are an early stage investor who has invested in one or more unicorns, you may qualify to join the TRAC Community. Limited to 100 members, Community members gain access to TRAC technology, deal flow and can earn a share of TRAC's carry. Show less



Blue Lizard Climbing and Yoga, LLC

• Co-Founder, Lead Guide

  • 2015 - Present

  We provide bouldering, yoga, hiking, pictograph, and photography tours at Hueco Tanks State Park and Historic Site. We provide bouldering, yoga, hiking, pictograph, and photography tours at Hueco Tanks State Park and Historic Site.



MarekPhotography

• Freelance Photographer

  • Jan 2004 - Present

  Concerts, sports, event photography, and portraits. Concerts, sports, event photography, and portraits.



El Paso Community College

• El Paso, Texas Area

• Engineering Instructor

  • Aug 2016 - May 2019

  Taught first and second year engineering courses, including Programming (C/C++), CAD (AutoCAD, Inventor), Introduction to Electrical Engineering, Electromechanical Systems, Introduction to Thermofluids, Engineering Economy, Dynamics. Taught first and second year engineering courses, including Programming (C/C++), CAD (AutoCAD, Inventor), Introduction to Electrical Engineering, Electromechanical Systems, Introduction to Thermofluids, Engineering Economy, Dynamics.



The University of Texas at Austin

• United States
• Higher Education
• 700 & Above Employee

• Lecturer

  • Aug 2011 - Jan 2016

  Teach laboratory courses to first-year and third-year biomedical engineering students; topics include the theory and use of: programming and robotics, drug delivery, circuit design and troubleshooting, acquisition and analysis of biopotentials, SolidWorks modeling, mammalian cell culture, mechanical properties and testing of materials, medical imaging, transport in hemodialysis, Design of Experiment, and statistical analysis of results

• Postdoctoral Fellow, Pharmaceutics

  • Jan 2010 - Aug 2011

  Pulmonary drug delivery; investigated the origins of adhesive/cohesive forces between DPI carrier, drug, and inhaler. Researched the cause of batch-to-batch variability in inhalation-grade lactose for dry powder inhalers. Pre-compressing lactose significantly decreased this variability. Determined the effect of surface chemistry, roughness, and energy on the adhesion of engineered particles to surfaces using the colloid probe AFM technique

• Graduate Research Assistant, Chemical Engineering

  • Aug 2005 - Dec 2009

  Synthesized and characterized enzyme-containing polymer films, microparticles, and nanoparticles for the intelligently triggered release of an encapsulated drug. Specifically, glucose oxidase was used to trigger the swelling of a cationic hydrogel system for the controlled release of insulin in the presence of high glucose levels.



Georgia Institute of Technology

• United States
• Higher Education
• 700 & Above Employee

• Undergraduate Research, Organic Chemistry

  • Sep 2002 - Dec 2004

  Synthesized di- and tetrasubstituted calix[4]arene derivatives, which dimerize in polar protic solvent, for use in drug delivery, phase transfer, and catalysis. Worked towards the total synthesis of the natural product (-)-dihydroguaiaretic acid and its analog as potential cancer drugs. Synthesized di- and tetrasubstituted calix[4]arene derivatives, which dimerize in polar protic solvent, for use in drug delivery, phase transfer, and catalysis. Worked towards the total synthesis of the natural product (-)-dihydroguaiaretic acid and its analog as potential cancer drugs.